SpotitEarly | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Email & Communication
Keywords & Focus Areas
SpotitEarly
Overview
SpotitEarly is a biotech company focused on developing non-invasive cancer screening technology that analyzes breath samples to detect early-stage cancer. Founded by a team with expertise in artificial intelligence, canine scent detection, and health technology, the company aims to make cancer screening more accessible and affordable.
The innovative approach combines trained detection dogs with advanced AI algorithms. Users collect breath samples at home using a test kit, which are then analyzed by specially trained dogs that identify volatile organic compounds associated with cancer. Proprietary AI technology interprets the dogs' signals, achieving a 94% accuracy rate in clinical trials. The company is conducting further studies and plans to launch its at-home cancer screening test commercially in the U.S. in 2026. Offerings include at-home cancer screening test kits, an AI-powered analysis platform, and partnerships with healthcare systems and research institutions. The company has raised over $20 million in investments and collaborates with regulatory bodies to ensure the safety and efficacy of its technology.
Basic Information
Industry | medical practice |
---|---|
Founded | 2020 |
Headquarters | Englewood, New Jersey, United States |
Contact Details
- Website: spotitearly.com
- LinkedIn: linkedin.com/company/spotitearly
Key Focus Areas & Initiatives
- Cancer screening
- Cancer diagnostics
- Innovation
- Breast cancer
- Lung cancer
- Colorectal cancer
- Prostate cancer
- Artificial intelligence
- Healthtech
- Healthcare
- Cancer
- Medical & diagnostic laboratories
- Biotechnology
- Canine scent detection
- Machine learning
- Cancer biomarkers
- AI analysis
- Olfactory sensors
- Non-invasive test
- Canine olfaction technology
- Scalable technology
- Bio-sensors
- Volatile organic compounds
- Breath science
- Clinical trials
- Nanotechnology
- Healthcare innovation
- Health tech
- Medical devices
- Cancer detection
- Sensitivity and specificity
- Scalable cancer screening
- Breath sample analysis
- VOC analysis
- Data science
- At-home testing
- Non-invasive screening
- Healthcare technology
- Clinical validation
- Diagnostics
- AI-powered diagnostics
- Cancer pre-screening
- Early cancer detection
- Real-time data analysis
- Odor signature detection
- Bio-AI hybrid system
- Bio-hybrid platform
- Olfactory biomarker detection
- Health IT
- Breath analysis
- Scalable lab systems
- Canine olfaction
- AI and scent science
- Medical diagnostics
- Non-invasive early diagnosis
- B2B
- B2C
- D2C
- Medical and diagnostic laboratories
- Information technology & services
- Health care
- Health, wellness & fitness
- Hospital & health care
- Medical practice
- Medical
Technologies Used
- AI
- Android
- Cloudflare DNS
- ElasticEmail
- Gmail
- Google Apps
- Google Cloud Hosting
- Google Tag Manager
- IoT
- Mobile Friendly
- Varnish
- Wix